Mr. Speaker, my question is for the Minister of Health.
The Director of the Bureau of Veterinary Drugs at Health Canada, who is currently on leave without pay, is lobbying MPs, on behalf of a group of private drug companies, regarding the virtues of bovine somatotropin.
Does the minister realize that this paradoxical situation in which her department finds itself, with a senior civil servant responsible for the Bureau of Veterinary Drugs now acting as a lobbyist for drug companies interested in marketing somatotropin?